Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-14 AKKARAJU SRINIVAS Director Conversion · Series B Preferred Stock −1,446,357 0
2023-02-14 Slingsby Brian Taylor Director Conversion +4,314,093 8,944,579
2023-02-14 Slingsby Brian Taylor Director Purchase +250,000 $16.00 $4.0M 9,194,579
2023-02-14 Slingsby Brian Taylor Director Conversion · Series A Preferred Stock −2,171,342 0
2023-02-14 Slingsby Brian Taylor Director Conversion · Series B Preferred Stock −2,142,751 0
2023-02-14 HBM Healthcare Investments (Cayman) Ltd. 10% owner Conversion +1,941,368 1,941,368
2023-02-14 HBM Healthcare Investments (Cayman) Ltd. 10% owner Conversion +964,238 2,905,606
2023-02-14 HBM Healthcare Investments (Cayman) Ltd. 10% owner Purchase +312,500 $16.00 $5.0M 3,218,106
2023-02-14 HBM Healthcare Investments (Cayman) Ltd. 10% owner Conversion · Series A Preferred Stock −20,962,895 0
2023-02-14 HBM Healthcare Investments (Cayman) Ltd. 10% owner Conversion · Series B Preferred Stock −10,411,846 0
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion +1,735,629 1,735,629
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Purchase +131,600 $16.00 $2.1M 1,867,229
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion +192,847 192,847
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Purchase +1,118,400 $16.00 $17.9M 1,311,247
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series B Preferred Stock −1,735,629 0
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series B Preferred Stock −192,847 0
2023-02-09 Slingsby Brian Taylor Director Grant or award · Stock Option +44,000 44,000
2023-02-09 DiRocco Derek Director Grant or award · Common Stock +44,000 44,000
2023-02-09 Takahashi Takeshi Director Grant or award · Stock Option +44,000 44,000
2023-02-09 Litzka Olivier Director Grant or award · Stock Option +44,000 44,000

Page 22 of 23 · 446 trades